{
    "clinical_study": {
        "@rank": "79104", 
        "arm_group": [
            {
                "arm_group_label": "Plasmalyte 3ml/kg/hr group", 
                "arm_group_type": "Active Comparator", 
                "description": "This group will have intravenous plasmalyte fluid limited to a rate of 3ml/kg/hr. and have the Nexfin Monitor placed on them"
            }, 
            {
                "arm_group_label": "Plasmalyte 6ml/kg/hr group", 
                "arm_group_type": "Active Comparator", 
                "description": "This group will have intravenous plasmalyte fluid limited to a rate of 6 ml/kg/hr. and the Nexfin Monitor placed on them"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to conduct a prospective, randomized, controlled trial\n      comparing a restrictive vs. conservative fluid strategy in thoracic surgery patients.\n      Excessive perioperative fluid has been retrospectively implicated in the development\n      postoperative acute lung injury (PALI) and pulmonary edema following lung resection.\n      However, fluid restriction in these patients is not without risk and may compromise end\n      organ perfusion (i.e. acute kidney injury).  The hypothesis is that a conservative fluid\n      approach in thoracic surgery patients will result in better end organ perfusion with fewer\n      occasions  of acute kidney injury (AKI) without causing an increase in postoperative acute\n      lung injury or pulmonary edema."
        }, 
        "brief_title": "Evaluating Fluid Strategies in Thoracic Surgery Patients Utilizing a Goal Directed Approach", 
        "completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Hypotension", 
            "Kidney Injury"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Hypotension", 
                "Wounds and Injuries"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  between 18-89 years of age\n\n          -  undergoing pulmonary lobectomy with open or video assisted thoracotomy\n\n        Exclusion Criteria:\n\n          -  patient refusal\n\n          -  pregnancy\n\n          -  cardiac arrhythmia\n\n          -  pacemaker dependency\n\n          -  severe aortic insufficiency\n\n          -  idiopathic hypertrophic subaortic stenosis\n\n          -  prisoners\n\n          -  decisionally challenged\n\n          -  patients that refuse to receive intravenous fluid products made from human    plasma\n             (Albumin 5%)\n\n          -  patients with skin infection or breakdown on their fingers\n\n          -  severe peripheral vascular disease\n\n          -  evidence of compromised finger perfusion will be excluded"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "89 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 6, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02135146", 
            "org_study_id": "13-1900", 
            "secondary_id": "13-1900"
        }, 
        "intervention": [
            {
                "arm_group_label": "Plasmalyte 3ml/kg/hr group", 
                "description": "This group will have intravenous plasmalyte fluid limited to a rate of 3 ml/kg/hr. and a nexfin monitor placed on them", 
                "intervention_name": "Plasmalyte 3ml/kg/hr group", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Plasmalyte 6ml/kg/hr group", 
                "description": "This group will have intravenous plasmalyte fluid limited to a rate of 6 ml/kg/hr. and a Nexfix Monitor placed on them", 
                "intervention_name": "Plasmalyte 6ml/kg/hr group", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Hypotension", 
            "Kidney injury"
        ], 
        "lastchanged_date": "May 7, 2014", 
        "location": {
            "contact": {
                "email": "colleen.dingmann@ucdenver.edu", 
                "last_name": "Colleen K Dingmann, R.N., Ph.D.", 
                "phone": "303-724-7494"
            }, 
            "facility": {
                "address": {
                    "city": "Aurora", 
                    "country": "United States", 
                    "state": "Colorado", 
                    "zip": "80138"
                }, 
                "name": "University of Colorado Hospital"
            }, 
            "investigator": [
                {
                    "last_name": "Meredith Goodwin, M.D.", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Tamas Seres, M.D. Ph.D.", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Evaluating Fluid Strategies in Thoracic Surgery Patients Utilizing a Goal Directed Approach", 
        "overall_contact": {
            "email": "colleen.dingmann@ucdenver.edu", 
            "last_name": "Colleen K Dingmann, R.N., Ph.D.", 
            "phone": "303-724-7494"
        }, 
        "overall_official": [
            {
                "affiliation": "University of Colorado, Denver", 
                "last_name": "Meredith Goodwin, M.D.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "University of Colorado, Denver", 
                "last_name": "Tamas Seres, M.D., PH.D.", 
                "role": "Study Chair"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Federal Government", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Acute renal injury as defined by the American Kidney Injury Network (AKIN) criteria in the first 72 hours postoperatively", 
                "measure": "Renal injury", 
                "safety_issue": "No", 
                "time_frame": "within 72 hours"
            }, 
            {
                "description": "Pulmonary Edema-as diagnosed independently by two, blinded radiologists using chest x-ray on postoperative day 0,1, and 2.  Pulmonary edema will be classified as none, mild, moderate or severe.", 
                "measure": "Pulmonary Edema", 
                "safety_issue": "No", 
                "time_frame": "Within 72 hours"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02135146"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Length of Surgical Intensive Unit stay/hospital Stay", 
                "measure": "Length of Surgical Intensive Unit stay/hospital Stay", 
                "safety_issue": "No", 
                "time_frame": "Within 7 days"
            }, 
            {
                "description": "Time to removal of Chest Tubes", 
                "measure": "Removal of Chest Tubes", 
                "safety_issue": "No", 
                "time_frame": "within 48 hours"
            }, 
            {
                "description": "Morbidity: acute lung injury, Acute Respiratory Distress, Deep Vein Thrombus, infection, delirium", 
                "measure": "Morbidity", 
                "safety_issue": "No", 
                "time_frame": "Within 7 days"
            }, 
            {
                "description": "Death", 
                "measure": "Death", 
                "safety_issue": "No", 
                "time_frame": "within 30 days"
            }, 
            {
                "description": "Arterial Blood Gases", 
                "measure": "Arterial Blood Gases", 
                "safety_issue": "No", 
                "time_frame": "For first 4 hours of Surgery"
            }
        ], 
        "source": "University of Colorado, Denver", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Colorado, Denver", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}